Project BioShield Compromise In House Could Serve As Senate Template
This article was originally published in The Gray Sheet
Executive Summary
A funding compromise between the White House and the House Energy & Commerce Committee for Project BioShield portends a similar agreement in the Senate
You may also be interested in...
Capitol Hill In Brief
MDUFMA oversight: Senate HELP Committee Chairman Judd Gregg (R-N.H.) is committed to ensuring that FDA receives the maximum funding needed to implement the Medical Device User Fee & Modernization Act, health counsel Steve Irizarry affirms at the Banc of America Securities Washington Healthcare Policy meeting May 7. "It's something that is apparently important to the Administration, to the FDA and to my boss, and we'll do everything we can, particularly my boss, [who] is an appropriator, to make sure FDA gets the requisite amounts," Irizarry pledged...
Bioshield Legislation Headed To Senate Floor Despite Objections Of Sen. Byrd
The Senate sponsors of a bill to authorize Project Bioshield will move the legislation to the floor even if a funding compromise cannot be reached with Senate Appropriations Committee Ranking Member Robert Byrd (D-W.Va.), according Senate HELP Committee staffers
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”